Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ha d an annual Consolidated EPS of $13.0018 for the period that ended on 2015-12-31. For the quarter ended 2015-12-31, the basic consolidated EPS stood at $13.0018.
EPS from continuing operations
In the annual period ended on 2015-12-31 as the basic Earnings per Share from continuing operations. As at 2015-12-31, the quarterly basic EPS was at $-0.28.
EPS contribution from parent
A basic EPS of $13.0018 was received from a parent firm in the annual period ended 2015-12-31. In quarter the session ended 2015-12-31, Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) received $13.0018 in basic EPS contribution.
Basic net EPS
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) registered a basic net EPS amounting to $13 for the year ended 2015-12-31. The net basic EPS of the company on quarterly basis for the three months ending on 2015-12-31 was at $13.
Consolidated diluted EPS
In the period ending on 2015-12-31, the annual consolidated diluted EPS reading was at $12.121. The consolidated diluted EPS stood at $12.121 for the quarter ended on 2015-12-31.
Basic diluted EPS
For the period ended 2015-12-31, $12.12 was the diluted EPS as a result of continuing operations on an annual basis. In the quarter period ended on 2015-12-31, a diluted EPS from continuing operations of $12.12 was recorded.
Net diluted EPS
A Net diluted EPS reading of $12.12 was registered for the period ending on 2015-12-31 while a net diluted EPS of $12.12 was recorded in the quarter period ended on 2015-12-31.
Diluted EPS from parent
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) received diluted EPS of from the parent company amounting to $12.121 for the year ended on 2015-12-31. A diluted EPS amounting to $12.121 was received on quarterly basis for the quarter period ended on 2015-12-31. A net basic EPS reading posted by the firm for the year ended on 2015-12-31 was $13. In the quarter period ended on 2015-12-31, a basic net EPS of $13 was posted.
In the period ended on 2015-12-31, the annual average basic shares outstanding 19.79 while 19.79 is for the quarter ended on 2015-12-31.In the fiscal year ended on 2015-12-31, diluted shares outstanding amount to 21.228 while 21.228 is for the quarter ended on 2015-12-31.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...